MEDICAL FACILITIES CORP (DR.CA) Stock Fundamental Analysis
Canada - TSX:DR - CA58457V5036 - Common Stock
14.27 CAD
-0.08 (-0.56%)
We assign a fundamental rating of 7 out of 10 to DR. DR was compared to 14 industry peers in the Health Care Providers & Services industry. DR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. DR is cheap, but on the other hand it scores bad on growth. These ratings could make DR a good candidate for value investing.
1. Profitability
1.1 Basic Checks
DR had positive earnings in the past year.
In the past year DR had a positive cash flow from operations.
Of the past 5 years DR 4 years were profitable.
In the past 5 years DR always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 30.18%, DR belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
The Return On Equity of DR (94.43%) is better than 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 15.42%, DR belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DR is significantly above the industry average of 7.17%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.18% | ||
| ROE | 94.43% | ||
| ROIC | 15.42% |
ROA(3y)8.42%
ROA(5y)6.13%
ROE(3y)25.39%
ROE(5y)18.93%
ROIC(3y)16.37%
ROIC(5y)14.6%
1.3 Margins
Looking at the Profit Margin, with a value of 31.60%, DR belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
DR's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 15.59%, DR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
DR's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 63.75%, DR belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
DR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.59% | ||
| PM (TTM) | 31.6% | ||
| GM | 63.75% |
OM growth 3Y-0.97%
OM growth 5Y-1.3%
PM growth 3Y78.64%
PM growth 5Y55.2%
GM growth 3Y-0.53%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DR is creating value.
DR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, DR has less shares outstanding
The debt/assets ratio for DR has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.31, we must say that DR is in the distress zone and has some risk of bankruptcy.
DR has a Altman-Z score of 1.31. This is in the better half of the industry: DR outperforms 64.29% of its industry peers.
DR has a debt to FCF ratio of 2.05. This is a good value and a sign of high solvency as DR would need 2.05 years to pay back of all of its debts.
The Debt to FCF ratio of DR (2.05) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 1.02 is on the high side and indicates that DR has dependencies on debt financing.
DR has a Debt to Equity ratio of 1.02. This is comparable to the rest of the industry: DR outperforms 57.14% of its industry peers.
Although DR does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.02 | ||
| Debt/FCF | 2.05 | ||
| Altman-Z | 1.31 |
ROIC/WACC1.77
WACC8.72%
2.3 Liquidity
DR has a Current Ratio of 1.79. This is a normal value and indicates that DR is financially healthy and should not expect problems in meeting its short term obligations.
DR has a Current ratio of 1.79. This is amongst the best in the industry. DR outperforms 100.00% of its industry peers.
A Quick Ratio of 1.67 indicates that DR should not have too much problems paying its short term obligations.
DR has a Quick ratio of 1.67. This is amongst the best in the industry. DR outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 38.24% over the past year.
Looking at the last year, DR shows a very negative growth in Revenue. The Revenue has decreased by -41.68% in the last year.
DR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.59% yearly.
EPS 1Y (TTM)38.24%
EPS 3Y10.86%
EPS 5Y0%
EPS Q2Q%18.11%
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y-5.96%
Revenue growth 5Y-3.59%
Sales Q2Q%-20.29%
3.2 Future
Based on estimates for the next years, DR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.76% on average per year.
DR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.10% yearly.
EPS Next Y32.59%
EPS Next 2Y9.79%
EPS Next 3Y10.76%
EPS Next 5YN/A
Revenue Next Year-21.98%
Revenue Next 2Y-11.46%
Revenue Next 3Y-7.1%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.81, the valuation of DR can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of DR indicates a rather cheap valuation: DR is cheaper than 92.86% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.07, DR is valued rather cheaply.
A Price/Forward Earnings ratio of 8.99 indicates a reasonable valuation of DR.
DR's Price/Forward Earnings ratio is rather cheap when compared to the industry. DR is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.08. DR is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.81 | ||
| Fwd PE | 8.99 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DR indicates a rather cheap valuation: DR is cheaper than 100.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, DR is valued cheaper than 92.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.86 | ||
| EV/EBITDA | 4.26 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y9.79%
EPS Next 3Y10.76%
5. Dividend
5.1 Amount
DR has a Yearly Dividend Yield of 2.53%. Purely for dividend investing, there may be better candidates out there.
DR's Dividend Yield is a higher than the industry average which is at 3.46.
Compared to an average S&P500 Dividend Yield of 2.44, DR has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
5.2 History
The dividend of DR decreases each year by -19.91%.
DR has paid a dividend for at least 10 years, which is a reliable track record.
DR has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-19.91%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
6.72% of the earnings are spent on dividend by DR. This is a low number and sustainable payout ratio.
DP6.72%
EPS Next 2Y9.79%
EPS Next 3Y10.76%
TSX:DR (11/20/2025, 7:00:00 PM)
14.27
-0.08 (-0.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners11.2%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap264.14M
Revenue(TTM)257.36M
Net Income(TTM)81.33M
Analysts42.22
Price Target16.58 (16.19%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.53% |
Yearly Dividend0.36
Dividend Growth(5Y)-19.91%
DP6.72%
Div Incr Years1
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.3%
Min Revenue beat(2)-4.5%
Max Revenue beat(2)1.91%
Revenue beat(4)1
Avg Revenue beat(4)-6.39%
Min Revenue beat(4)-18.84%
Max Revenue beat(4)1.91%
Revenue beat(8)3
Avg Revenue beat(8)-3.49%
Revenue beat(12)4
Avg Revenue beat(12)-2.43%
Revenue beat(16)5
Avg Revenue beat(16)-2.23%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)50.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.81 | ||
| Fwd PE | 8.99 | ||
| P/S | 0.73 | ||
| P/FCF | 3.86 | ||
| P/OCF | 3.55 | ||
| P/B | 2.19 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.26 |
EPS(TTM)1.32
EY9.25%
EPS(NY)1.59
Fwd EY11.13%
FCF(TTM)3.7
FCFY25.92%
OCF(TTM)4.02
OCFY28.17%
SpS19.48
BVpS6.52
TBVpS-0.86
PEG (NY)0.33
PEG (5Y)N/A
Graham Number13.92
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.18% | ||
| ROE | 94.43% | ||
| ROCE | 18.66% | ||
| ROIC | 15.42% | ||
| ROICexc | 19.71% | ||
| ROICexgc | 46.81% | ||
| OM | 15.59% | ||
| PM (TTM) | 31.6% | ||
| GM | 63.75% | ||
| FCFM | 18.99% |
ROA(3y)8.42%
ROA(5y)6.13%
ROE(3y)25.39%
ROE(5y)18.93%
ROIC(3y)16.37%
ROIC(5y)14.6%
ROICexc(3y)21.7%
ROICexc(5y)18.79%
ROICexgc(3y)53.59%
ROICexgc(5y)43.79%
ROCE(3y)19.81%
ROCE(5y)17.76%
ROICexgc growth 3Y35.06%
ROICexgc growth 5Y23.36%
ROICexc growth 3Y18.42%
ROICexc growth 5Y13.1%
OM growth 3Y-0.97%
OM growth 5Y-1.3%
PM growth 3Y78.64%
PM growth 5Y55.2%
GM growth 3Y-0.53%
GM growth 5Y-0.42%
F-Score6
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.02 | ||
| Debt/FCF | 2.05 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 25.03% | ||
| Cap/Sales | 1.64% | ||
| Interest Coverage | 7.65 | ||
| Cash Conversion | 93.1% | ||
| Profit Quality | 60.09% | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 1.31 |
F-Score6
WACC8.72%
ROIC/WACC1.77
Cap/Depr(3y)47.79%
Cap/Depr(5y)40.36%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.24%
EPS 3Y10.86%
EPS 5Y0%
EPS Q2Q%18.11%
EPS Next Y32.59%
EPS Next 2Y9.79%
EPS Next 3Y10.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y-5.96%
Revenue growth 5Y-3.59%
Sales Q2Q%-20.29%
Revenue Next Year-21.98%
Revenue Next 2Y-11.46%
Revenue Next 3Y-7.1%
Revenue Next 5YN/A
EBIT growth 1Y-46.1%
EBIT growth 3Y-6.86%
EBIT growth 5Y-4.85%
EBIT Next Year0.87%
EBIT Next 3Y1.59%
EBIT Next 5YN/A
FCF growth 1Y-6.31%
FCF growth 3Y4.28%
FCF growth 5Y3.38%
OCF growth 1Y-24.65%
OCF growth 3Y3.26%
OCF growth 5Y1.55%
MEDICAL FACILITIES CORP / DR.CA FAQ
What is the fundamental rating for DR stock?
ChartMill assigns a fundamental rating of 7 / 10 to DR.CA.
What is the valuation status for DR stock?
ChartMill assigns a valuation rating of 9 / 10 to MEDICAL FACILITIES CORP (DR.CA). This can be considered as Undervalued.
Can you provide the profitability details for MEDICAL FACILITIES CORP?
MEDICAL FACILITIES CORP (DR.CA) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for DR stock?
The Price/Earnings (PE) ratio for MEDICAL FACILITIES CORP (DR.CA) is 10.81 and the Price/Book (PB) ratio is 2.19.
Can you provide the dividend sustainability for DR stock?
The dividend rating of MEDICAL FACILITIES CORP (DR.CA) is 5 / 10 and the dividend payout ratio is 6.72%.